الفهرس | Only 14 pages are availabe for public view |
Abstract Othe past decade, there has been an increase in the use of hematopoietic stem cell transplants (HSCT) to treat hematologic malignancies, life-threatening nonmalignant hematologic disorders and a continuously expanding list of diseases. Even after using newer, less intensive regimens, patients undergoing HSCT still receive frequent blood products as part of their supportive therapy which had impacted transfusion service all over the world. In light of substantial cost and some risk associated with blood product use and the fact that the role of blood transfusion in clinical outcomes in patients undergoing HSCT still poorly understood we pursued a detailed study to gain more insight and knowledge about blood component transfusion practices in populations undergoing HSCT. Hence, the aim of this study was to investigate the relationship between blood transfusion and the following sequels that has been recognized to hematopoietic stem cell transplantation such as the incidence of infection‚ acute and chronic GVHD and overall survival Using retrospectively collected data from the Ain shams Bone Marrow Transplant unit records, we reviewed demographics and complications in 50adult patients who underwent HSCT. This was supplemented with complete and detailed transfusion data for 3 months before to 1 year after HSCT. The survival time of these patients was tracked over a period of 3 years. The patients were divided into 2 groups:- 30 patients who received less than 10 units (group 1) and 20 patients who received more than 10 units (group 2). To evaluate the relation between the amount of blood consumed and the outcome of HSCT. After analyzing the collected data we found that there was a positive relationship between amount of blood transfusions and the rate of infection but no impact on the time of infection was observed. There was a positive relationship between the amount of blood transfusions and incidence of GVHD but no impact on the affected organs nor the type of GVHD was observed. Finally, there was a positive relationship between the amount of blood transfusion and the decreased median time for survival which was estimated in this study as 2 years. |